Obagi Medical Products, Inc. (NASDAQ:OMPI)

CAPS Rating: 4 out of 5

A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems.

Recs

0
Player Avatar suffysdad (83.38) Submitted: 6/10/2008 7:54:15 PM : Outperform Start Price: $8.63 OMPI Score: +46.88

Strong fundamentals are currently undervalued.

Featured Broker Partners


Advertisement